Novo Ventures
Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.
...Homepage: http://www.novo.dk/composite-1.htm
Bagsvaerd
DNK
Phone: +45 88 24 88 24
Novo Ventures at CrunchBase
Ulf J. Johansson Chairman of the board
Past
March, 2013
Novo Ventures invested $48M in Nevro as a Series C round
January, 2013
Novo Ventures invested $19.5M in Ceterix Orthopaedics as a Series B round
December, 2012
Novo Ventures invested $20M in Flexion Therapeutics as a Series B round
October, 2012
Novo Ventures invested $16M in Thesan Pharmaceuticals as a Series A round
April, 2012
Novo Ventures invested $38M in Alder Biopharmaceuticals as a Series D round
January, 2012
Novo Ventures invested $30M in Elevation Pharmaceuticals as a Series B round
October, 2011
Novo Ventures invested $40M in Imagen Biotech as a Series A round
May, 2011
Novo Ventures invested $19.3M in Delenex Therapeutics as a Series A round
April, 2011
Novo Ventures invested $20.3M in f-star Biotech as unattributed round
August, 2010
Novo Ventures invested $38.5M in Otonomy as a Series B round
June, 2010
Novo Ventures invested $29M in Foldrx Pharmaceuticals as unattributed round
May, 2010
Novo Ventures invested $12.2M in Funxional Therapeutics as a Series B round
Novo Ventures invested $43M in NeuroTherapeutics Pharma as a Series B round
January, 2010
Novo Ventures invested $30M in Neomend as a Series D round
Novo Ventures invested $24M in Tarsa Therapeutics as a Series A round
November, 2009
Novo Ventures invested $8.6M in Metabolex as unattributed round
August, 2009
Novo Ventures invested $29M in Gloucester Pharmaceuticals as a Series D round
June, 2009
Novo Ventures invested $23M in MediQuest Therapeutics as a Series B round
Novo Ventures invested $8M in Alios BioPharma as a Series A round
February, 2009
Novo Ventures invested $24M in Alios BioPharma as a Series A round
January, 2009
Novo Ventures invested $29M in Synosia Therapeutics as a Series B round
April, 2007
Novo Ventures invested $32M in Metabolex as a Series D round
January, 2006
Novo Ventures invested $27M in ProteinSimple as a Series B round